Literature DB >> 20974942

Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.

Kohki Kawane1, Hiromi Tanaka, Yusuke Kitahara, Shin Shimaoka, Shigekazu Nagata.   

Abstract

DNase II digests the chromosomal DNA in macrophages after apoptotic cells and nuclei from erythroid precursors are engulfed. The DNase II-null mice develop a polyarthritis that resembles rheumatoid arthritis. Here, we showed that when bone marrow cells from the DNase II-deficient mice were transferred to the wild-type mice, they developed arthritis. A deficiency of Rag2 or a lack of lymphocytes accelerated arthritis of the DNase II-null mice, suggesting that the DNase II(-/-) macrophages were responsible for triggering arthritis, and their lymphocytes worked protectively. A high level of TNFα, IL-1β, and IL-6 was found in the affected joints of the DNase II-null mice, suggesting an inflammatory-skewed cytokine storm was established in the joints. A lack of TNFα, IL-1β, or IL-6 gene blocked the expression of the other cytokine genes as well and inhibited the development of arthritis. Neutralization of TNFα, IL-1β, or IL-6 had a therapeutic effect on the developed arthritis of the DNase II-null mice, indicating that the cytokine storm was essential for the maintenance of arthritis in the DNase II-deficient mice. Methotrexate, an antimetabolite that is often used to treat patients with rheumatoid arthritis, had a therapeutic effect with the DNase II-null mice. These properties of arthritis in the DNase II-null mice were similar to those found in human systemic-onset juvenile idiopathic arthritis or Still's disease, indicating that the DNase II-null mice are a good animal model of this type of arthritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974942      PMCID: PMC2984163          DOI: 10.1073/pnas.1010603107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Characterization of anti-mouse interleukin-6 receptor antibody.

Authors:  Makoto Okazaki; Yoshiki Yamada; Norihiro Nishimoto; Kazuyuki Yoshizaki; Masahiko Mihara
Journal:  Immunol Lett       Date:  2002-12-03       Impact factor: 3.685

3.  Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver.

Authors:  K Kawane; H Fukuyama; G Kondoh; J Takeda; Y Ohsawa; Y Uchiyama; S Nagata
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

4.  Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18.

Authors:  X Q Wei; B P Leung; H M Arthur; I B McInnes; F Y Liew
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

5.  Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.

Authors:  Rachelle Donn; Zaynab Alourfi; Fabrizio De Benedetti; Cristina Meazza; Eleftheria Zeggini; Mark Lunt; Adam Stevens; Emma Shelley; Rebecca Lamb; William E R Ollier; Wendy Thomson; David Ray
Journal:  Arthritis Rheum       Date:  2002-09

6.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

7.  Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

Authors:  R Horai; S Saijo; H Tanioka; S Nakae; K Sudo; A Okahara; T Ikuse; M Asano; Y Iwakura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

Review 8.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12

Review 9.  A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?

Authors:  C Benoist; D Mathis
Journal:  Arthritis Res       Date:  2000-02-24

10.  Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.

Authors:  Hong Ji; Allison Pettit; Koichiro Ohmura; Adriana Ortiz-Lopez; Veronique Duchatelle; Claude Degott; Ellen Gravallese; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  49 in total

1.  Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Authors:  Jamie C Merrill; Jian You; Cara Constable; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation.

Authors:  Maria L Mouchess; Nicholas Arpaia; Gianne Souza; Roman Barbalat; Sarah E Ewald; Laura Lau; Gregory M Barton
Journal:  Immunity       Date:  2011-11-10       Impact factor: 31.745

3.  Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.

Authors:  Kevin B Walsh; John R Teijaro; Peter R Wilker; Anna Jatzek; Daniel M Fremgen; Subash C Das; Tokiko Watanabe; Masato Hatta; Kyoko Shinya; Marulasiddappa Suresh; Yoshihiro Kawaoka; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-29       Impact factor: 11.205

4.  Role of Interferon-γ-Producing Th1 Cells in a Murine Model of Type I Interferon-Independent Autoinflammation Resulting From DNase II Deficiency.

Authors:  Sudesh Pawaria; Kerstin Nündel; Kevin M Gao; Stephanie Moses; Patricia Busto; Kevin Holt; Rohit B Sharma; Michael A Brehm; Ellen M Gravallese; Merav Socolovsky; Anette Christ; Ann Marshak-Rothstein
Journal:  Arthritis Rheumatol       Date:  2019-12-29       Impact factor: 10.995

5.  Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.

Authors:  Angela Lee; Yu Qiao; Galina Grigoriev; Janice Chen; Kyung-Hyun Park-Min; Sung Ho Park; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheum       Date:  2013-04

6.  Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection.

Authors:  John R Teijaro; Kevin B Walsh; Stephanie Rice; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-26       Impact factor: 11.205

7.  DNA degradation and its defects.

Authors:  Kohki Kawane; Kou Motani; Shigekazu Nagata
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

8.  STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice.

Authors:  Rebecca Baum; Shruti Sharma; Jason M Organ; Christopher Jakobs; Veit Hornung; David B Burr; Ann Marshak-Rothstein; Katherine A Fitzgerald; Ellen M Gravallese
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 9.  Nucleic Acid-Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation.

Authors:  Shruti Sharma; Katharine A Fitzgerald; Michael P Cancro; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-10-15       Impact factor: 5.422

10.  Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.

Authors:  Linda N Liu; Gang Wang; Kyle Hendricks; Keunmyoung Lee; Ernst Bohnlein; Uwe Junker; Joseph D Mosca
Journal:  Stem Cells Transl Med       Date:  2013-04-16       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.